(Q40897162)

24 September 2017

Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster (English)

1 reference

24 September 2017

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

5

E R Moxon

1 reference

24 September 2017

R Booy

1

1 reference

24 September 2017

P T Heath

series ordinal

2

1 reference

24 September 2017

M P Slack

series ordinal

3

1 reference

24 September 2017

N Begg

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

24 September 2017

1 reference

24 September 2017

349

1 reference

24 September 2017

9060

1 reference

24 September 2017

1197-1202

1 reference

The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

The impact of conjugate vaccine on carriage of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Epidemiology of Haemophilus influenzae type b invasive disease in Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Prospective study of bacterial meningitis in North East Thames region, 1991-3, during introduction of Haemophilus influenzae vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Second episodes of Haemophilus influenzae type b disease following rifampin prophylaxis of the index patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Enhanced antibody response in Venezuelan infants immunized with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

Assessing the human condition: capture-recapture techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906392-1

7 January 2021

10.1016/S0140-6736(96)06392-1

Identifiers

DOI

1 reference

24 September 2017

1 reference